Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.72%142.38B | 3.90%611.11B | 2.57%175.64B | 0.72%149.82B | 2.86%153.48B | 11.11%132.17B | 25.42%588.16B | 20.77%171.23B | 34.40%148.75B | 27.20%149.22B |
Cost of revenue | 7.25%98.3B | 1.36%414B | -0.19%116.76B | -0.99%102.79B | 0.32%102.79B | 7.60%91.65B | 23.53%408.46B | 18.73%116.99B | 28.68%103.82B | 26.20%102.47B |
Gross profit | 8.78%44.08B | 9.69%197.11B | 8.54%58.88B | 4.67%47.02B | 8.43%50.69B | 19.97%40.52B | 29.92%179.7B | 25.42%54.25B | 49.78%44.93B | 29.44%46.75B |
Operating expense | 7.21%34.14B | 6.77%131.75B | 3.91%34.67B | 8.41%33.6B | 4.95%31.63B | 10.22%31.85B | 20.00%123.39B | 23.98%33.36B | 22.97%30.99B | 18.17%30.14B |
Operating profit | 14.54%9.93B | 16.08%65.36B | 15.93%24.21B | -3.67%13.42B | 14.73%19.06B | 77.65%8.67B | 58.67%56.31B | 27.78%20.88B | 190.90%13.93B | 56.50%16.61B |
Net non-operating interest income (expenses) | 563.38%658M | 155.20%260M | 281.35%350M | 157.26%67M | 83.15%-15M | -97.22%-142M | -61.86%-471M | -278.43%-193M | -185.37%-117M | 16.04%-89M |
Non-operating interest income | 1,285.71%970M | 935.92%1.47B | 1,123.73%722M | 1,437.50%369M | 1,007.14%310M | 125.81%70M | -10.69%142M | 22.92%59M | -56.36%24M | 64.71%28M |
Non-operating interest expense | 47.17%312M | 97.55%1.21B | 47.62%372M | 114.18%302M | 177.78%325M | 105.83%212M | 36.22%613M | 154.55%252M | 46.88%141M | -4.88%117M |
Net investment income | 25.17%373M | 233.33%720M | 163.75%51M | 547.62%94M | 125.20%277M | 53.61%298M | -63.27%216M | -147.06%-80M | -133.33%-21M | 78.26%123M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -4,800.00%-188M | 1M | -5M | -83.33%4M | 0 | 0 | ||||
Income from associates and other participating interests | 185.19%46M | 86.65%-84M | 99.28%-2M | 128.09%25M | 64.90%-53M | 52.21%-54M | -188.53%-629M | -1,633.33%-276M | -456.25%-89M | 4.43%-151M |
Special income (charges) | -40.89%-379M | 48.24%-2.79B | -70.81%-6.78B | 106.97%14M | 1,038.94%4.24B | 65.11%-269M | -286.67%-5.39B | -203.28%-3.97B | -204.55%-201M | -2,558.82%-452M |
Less:Restructuring and mergern&acquisition | ---- | -13.35%318M | -10.12%293M | -83.33%3M | ---- | ---- | 132.28%367M | 302.47%326M | -74.29%18M | ---- |
Less:Other special charges | 40.89%379M | -238.93%-2.19B | 839.69%1.82B | -109.29%-17M | -1,094.41%-4.27B | -65.11%269M | 27.49%1.58B | -84.20%194M | 4,675.00%183M | 2,423.53%429M |
Less:Write off | ---- | 35.22%4.67B | ---- | ---- | ---- | ---- | --3.45B | ---- | ---- | ---- |
Other non-operating income (expenses) | -1.29%-235M | -2.40%-980M | 32.18%-274M | 3.45%-224M | -77.30%-250M | -28.89%-232M | -94.91%-957M | -286.18%-404M | 32.56%-232M | 35.91%-141M |
Income before tax | 25.63%10.4B | 26.94%62.29B | 9.96%17.55B | 0.93%13.39B | 45.06%23.08B | 110.11%8.27B | 45.61%49.08B | 3.54%15.96B | 202.69%13.27B | 56.22%15.91B |
Income tax | 25.82%3B | 19.04%18.82B | 2.26%5.7B | 1.48%3.99B | 35.86%6.75B | 78.06%2.39B | 48.09%15.81B | 31.91%5.57B | 120.35%3.93B | 46.71%4.97B |
Net income | 25.58%7.39B | 30.69%43.47B | 14.11%11.85B | 0.71%9.41B | 49.25%16.33B | 126.60%5.89B | 44.46%33.26B | -7.18%10.38B | 259.33%9.34B | 60.95%10.94B |
Net income continuous operations | 25.56%7.39B | 30.69%43.47B | 14.10%11.85B | 0.71%9.41B | 49.24%16.33B | 126.64%5.89B | 44.46%33.27B | -7.17%10.39B | 259.19%9.34B | 60.95%10.94B |
Noncontrolling interests | 24.07%67M | 35.56%244M | 1.41%72M | 10.71%62M | 80.65%56M | 145.45%54M | -1.64%180M | 86.84%71M | 36.59%56M | -62.65%31M |
Net income attributable to the company | 25.60%7.33B | 30.66%43.23B | 14.20%11.78B | 0.62%9.34B | 49.16%16.28B | 126.52%5.83B | 44.84%33.08B | -7.49%10.31B | 262.80%9.28B | 62.48%10.91B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 25.60%7.33B | 30.66%43.23B | 14.20%11.78B | 0.62%9.34B | 49.16%16.28B | 126.52%5.83B | 44.84%33.08B | -7.49%10.31B | 262.80%9.28B | 62.48%10.91B |
Gross dividend payment | ||||||||||
Basic earnings per share | 26.94%33.5 | 30.94%196.03 | 15.00%53.67 | 0.83%42.35 | 49.09%73.62 | 126.33%26.39 | 44.79%149.71 | -7.51%46.67 | 262.38%42 | 62.43%49.38 |
Diluted earnings per share | 27.00%33.44 | 30.95%195.56 | 15.02%53.54 | 0.81%42.25 | 49.12%73.44 | 126.40%26.33 | 44.81%149.34 | -7.51%46.55 | 262.86%41.91 | 62.43%49.25 |
Dividend per share | 0 | 34.48%78 | 48.48%49 | 0 | 16.00%29 | 0 | 61.11%58 | 73.68%33 | 0 | 47.06%25 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |